Glycinorm-M 80/500mg Tablet (Gliclazide/Metformin): A Comprehensive Overview
The Gliclazide and Metformin that are contained within a Glycinorm-M 80/500mg Tablet make up the two active components of this combo medication. It is a medication that is frequently recommended for the management of diabetes mellitus type 2. In the following paragraphs, we will present a comprehensive overview of the Glycinorm-M 80/500mg Tablet, covering its primary characteristics, uses, dosage, potential adverse effects, and safety considerations.
Key Features of Glycinorm-M 80/500mg Tablet
- Combination Medication: The Glycinorm-M 80/500mg Tablet is a combination medication that combines Gliclazide and Metformin, two medications that are used to treat diabetes. Gliclazide, a drug that belongs to the sulfonylurea class and helps promote the production of insulin from the pancreas, is also known as gliclazide. Metformin, on the other hand, is a biguanide that enhances insulin sensitivity while simultaneously decreasing the amount of glucose produced by the liver.
- Indications: The treatment of diabetes mellitus type 2 in adults is the primary indication for the use of the Glycinorm-M 80/500mg Tablet. Individuals who are unable to achieve optimal glycemic control with lifestyle adjustments alone may benefit from using this medication to help control their blood sugar levels.
- Dosage: The recommended daily intake of Glycinorm-M 80/500mg Tablet should be individualised for each patient based on their age, current medical condition, and how well they respond to treatment. It is essential to ensure that the dosage and administration instructions provided by the healthcare professional are strictly adhered to at all times. Adults should begin treatment with the standard starting dose of one tablet, to be taken orally with meals once or twice daily. However, the dosage can be modified in accordance with the requirements of the individual.
- Chewing or crushing the Glycinorm-M 80/500mg Tablet before swallowing is not recommended during administration. The tablet should be taken with a full glass of water. It is possible to lessen the likelihood of experiencing adverse effects on the gastrointestinal tract by taking the drug in conjunction with meals. It is absolutely necessary to stick to the specified schedule and to not exceed the appropriate dosage without first seeing a healthcare professional.
- Side Effects: The Glycinorm-M 80/500mg Tablet, like any other medicine, has the potential to induce a variety of adverse side effects. Symptoms of gastrointestinal distress, such as nausea, vomiting, diarrhoea, and abdominal discomfort, are among the most often reported adverse effects. Hypoglycemia, commonly known as low blood sugar levels, is another possible side effect of taking Glycinorm-M 80/500mg Tablet, particularly when the medication is combined with other diabetes medications. It is essential to be aware of these possible adverse effects and to seek medical assistance in the event that they continue or become more severe.
- Individuals who have a history of hypersensitivity to gliclazide, metformin, or any of the other components of the tablet should not take the Glycinorm-M 80/500mg Tablet. This medication carries a number of precautions and warnings. Patients who have a history of lactic acidosis, diabetes mellitus type 1, diabetic ketoacidosis, severe renal illness, or liver disease, or who should not use this medication include those patients. During therapy with Glycinorm-M 80/500mg Tablet, it is advised that patients keep a close eye on their blood sugar levels and visit their doctor on a consistent basis.
Related Product
Glycinorm 40 Tablet
Glycinorm 80 Tablet
Glycinorm 160 Tablet
Glycinorm OD 30mg Tablet
Glycinorm OD 60mg Tablet
Glycinorm Total 30 Tablet
Glycinorm Total 60 Tablet
Glycinorm M 30 OD Tablet
Glycinorm M 60 OD Tablet
Glycinorm M 40 Tablet
Glycinorm M 80 Tablet
Uses of Glycinorm-M 80/500mg Tablet
The control of diabetes mellitus type 2 is the primary application for the usage of the Glycinorm-M 80/500mg Tablet. It does an efficient job of controlling blood sugar levels because it combines the mechanisms of action of the diabetes drugs gliclazide and metformin. Gliclazide increases the amount of insulin that is secreted by the pancreas, whereas metformin lowers the amount of glucose that is produced by the liver and increases the sensitivity of the body to insulin. This combined therapy helps achieve better control of blood sugar levels and lowers the risk of long-term problems that are linked with diabetes.
Dosage and Administration
A healthcare expert should establish the appropriate dosage of Glycinorm-M 80/500mg Tablet based on individual criteria such as age, renal function, and responsiveness to treatment. These factors can vary from patient to patient. It is absolutely necessary to strictly adhere to the dosage and administration directions that have been provided. To reduce the likelihood of experiencing any adverse effects on the gastrointestinal tract, the tablet should be swallowed with food. It is essential to take the medication exactly as prescribed and not increase the dosage or make any other adjustments until speaking with a medical professional.
Common Side Effects
It is possible that the Glycinorm-M 80/500mg Tablet will cause specific adverse effects in some people. The most typical adverse reactions involve the gastrointestinal system and include symptoms such as nausea, vomiting, diarrhoea, and discomfort in the abdominal region. These unwanted effects are often modest and short-lived, and they go away as the body becomes accustomed to the medication. Hypoglycemia, which can be identified by symptoms including sweating, dizziness, and confusion, is another possibility. It is critical to keep a regular check on blood sugar levels and get medical assistance if any unwanted effects continue or become problematic.
Rare but Serious Side Effects
There have been isolated reports of Glycinorm-M 80/500mg Tablet causing adverse effects that could be considered significant. Some examples of these are severe allergic reactions, dysfunction of the liver, and lactic acidosis. The accumulation of lactic acid in the body is the primary symptom of lactic acidosis, a condition that is extremely uncommon but can be fatal. Symptoms can include rapid breathing, soreness in the muscles, weakness, discomfort in the abdomen region, vertigo, and an irregular heartbeat. In the event that any of these symptoms manifest themselves, it is imperative that prompt medical assistance be sought.
Precautions and Warnings
Before beginning therapy with Glycinorm-M 80/500mg Tablet, it is vital to inform the healthcare practitioner about any preexisting medical conditions, drugs that are currently being taken, or allergies that the patient may have. This will assist ensure that the medication is used in a way that is both safe and effective. In patients who have been shown to have an extreme sensitivity to gliclazide, metformin, or any of the other components of the tablet, the use of the Glycinorm-M 80/500mg Tablet is strictly prohibited. Patients who have compromised renal function, liver illness, or a previous history of lactic acidosis should also be treated with caution when using this medication.
Conclusion
Gliclazide and metformin are the active ingredients in the combination drug known as Glycinorm-M 80/500mg Tablet, which is used for the control of type 2 diabetes mellitus. It is an efficient means of controlling blood sugar levels due to the combination of the actions of gliclazide and metformin. The Glycinorm-M 80/500mg Tablet may produce gastrointestinal adverse effects as well as hypoglycemia, despite the fact that it is normally well tolerated. Even though serious adverse effects are uncommon, prompt medical intervention is still required. For the best possible outcomes, it is essential to adhere to the advice made by the healthcare professional regarding the dosage, any necessary precautions, and monitoring of the patient. In order to make sure that you are using Glycinorm-M 80/500mg Tablet in a way that is both safe and effective, you will need to consult with a medical practitioner on a regular basis.
